Brief: Cytek Biosciences Q4 Revenue USD 57.5 Million Vs. IBES Estimate USD 59.4 Million
27/02/2025 21:05
Feb 27 (Reuters) - Cytek Biosciences Q4 adjusted EBITDA USD 12.532 million. Q4 adjusted gross margin 59% Q4 net income USD 9.6 million vs. IBES estimate USD 6.67 million outlook FY revenue USD 204-212 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million